Anthony Simon Harvey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anthony Simon Harvey has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
- Samuel F. Berkovic
Epilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, VIC 3084, Australia
9 shared publications - Aaron E. L. Warren
Department of Neurosurgery Mass General Brigham, Harvard Medical School Boston Massachusetts USA
7 shared publications - Emma Macdonald‐Laurs
Clinical Sciences Murdoch Children's Research Institute Melbourne Victoria Australia
7 shared publications Jeremy L. Freeman
7 shared publications- Sarah Barton
Department of Neurosurgery, Royal Children’s Hospital, Parkville, VIC, Australia
7 shared publications Duncan MacGregor
Murdoch Children's Research Institute Parkville Victoria Australia
5 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Wolters Kluwer Health in Neurosurgery
Pediatric Epilepsy Surgery: Global Survey of Surgical Approaches
BACKGROUND AND OBJECTIVES: Pediatric epilepsy surgery is an established treatment, but current global data on surgical practices are limited. This study, conducted by the International League Against Epilepsy Pediatric Epilepsy Surgery Taskforce, provides an updated international overview of surgical approaches and their regional variation. METHODS: Group-level data were collected from 61 epilepsy surgery programs (49 pediatric-only) across 29 countries on 6 continents. All children and adolescents who underwent epilepsy surgery in 2023 were included. The study was designed to enable direct comparison with the similar survey conducted by the International League Against Epilepsy in 2004. RESULTS: The cohort comprised 2427 patients. Resections accounted for 50.6% and disconnections for 23.0% of procedures. Resection rates were highest in Oceania (87.3%) and lowest in North America (40.3%). Resections were 43.0% unilobar—most commonly temporal (39.6%) and frontal (32.7%)—and 9.7% multilobar, with 61.9% involving the posterior quadrant. Hemispheric surgeries comprised 12.9% of all cases (highest in South America: 18.1%). Subcortical procedures (eg, for hypothalamic hamartomas or deep-seated lesions) represented 2.7% (highest in South America: 12.1%). Intraoperative electrocorticography was used in 38.3% of cases, most commonly in Oceania (84.1%) and Asia (85.5%). Minimally invasive techniques were used in 7.7% of cases, with the highest rate in North America (16.9%). Laser interstitial thermal therapy was most common (4.9%), followed by radiofrequency ablation (2.1%), endoscopic surgery (0.7%), and radiosurgery (0.1%). Corpus callosotomy was performed in 5.9% of all cases, and no multiple subpial transections were reported. Neurostimulation was used in 14.7% of patients, highest in North America (35.6%), and included vagal nerve stimulation (11.8%), deep brain stimulation (1.5%), and responsive neurostimulation (1.4%). CONCLUSION: Resections and disconnections, including extensive multilobar and hemispheric procedures, remain the core procedures of pediatric epilepsy surgery. Although minimally invasive and neuromodulatory techniques are increasingly used in selected regions—particularly North America—their global adoption remains limited.
- 3 November 2026
- Published by Wolters Kluwer Health in Neurosurgery
Open AccessPediatric Epilepsy Surgery: Global Survey of Surgical Approaches
BACKGROUND AND OBJECTIVES: Pediatric epilepsy surgery is an established treatment, but current global data on surgical practices are limited. This study, conducted by the International League Against Epilepsy Pediatric Epilepsy Surgery Taskforce, provides an updated international overview of surgical approaches and their regional variation. METHODS: Group-level data were collected from 61 epilepsy surgery programs (49 pediatric-only) across 29 countries on 6 continents. All children and adolescents who underwent epilepsy surgery in 2023 were included. The study was designed to enable direct comparison with the similar survey conducted by the International League Against Epilepsy in 2004. RESULTS: The cohort comprised 2427 patients. Resections accounted for 50.6% and disconnections for 23.0% of procedures. Resection rates were highest in Oceania (87.3%) and lowest in North America (40.3%). Resections were 43.0% unilobar—most commonly temporal (39.6%) and frontal (32.7%)—and 9.7% multilobar, with 61.9% involving the posterior quadrant. Hemispheric surgeries comprised 12.9% of all cases (highest in South America: 18.1%). Subcortical procedures (eg, for hypothalamic hamartomas or deep-seated lesions) represented 2.7% (highest in South America: 12.1%). Intraoperative electrocorticography was used in 38.3% of cases, most commonly in Oceania (84.1%) and Asia (85.5%). Minimally invasive techniques were used in 7.7% of cases, with the highest rate in North America (16.9%). Laser interstitial thermal therapy was most common (4.9%), followed by radiofrequency ablation (2.1%), endoscopic surgery (0.7%), and radiosurgery (0.1%). Corpus callosotomy was performed in 5.9% of all cases, and no multiple subpial transections were reported. Neurostimulation was used in 14.7% of patients, highest in North America (35.6%), and included vagal nerve stimulation (11.8%), deep brain stimulation (1.5%), and responsive neurostimulation (1.4%). CONCLUSION: Resections and disconnections, including extensive multilobar and hemispheric procedures, remain the core procedures of pediatric epilepsy surgery. Although minimally invasive and neuromodulatory techniques are increasingly used in selected regions—particularly North America—their global adoption remains limited.
- Open Access
Pediatric epilepsy surgery: Global survey of invasive explorations
Objective: Invasive presurgical evaluation plays a key role in pediatric epilepsy surgery, particularly in magnetic resonance imaging (MRI)‐negative cases, by guiding resective, disconnective, or ablative procedures. This International League Against Epilepsy (ILAE) Pediatric Epilepsy Surgery Taskforce study provides an updated global overview of current invasive evaluation practices. Methods: Group‐level data were collected from 61 epilepsy surgery programs (49 pediatric‐only) in 29 countries across six continents. Included were children and adolescents who underwent presurgical evaluation and epilepsy surgery in 2023. The study was designed to enable comparison with the similar ILAE survey conducted in 2004. Results: A total of 2427 patients were included. Invasive evaluations were performed in 21.1% of cases, most frequently in North America (33.7%, higher than Europe: 18.0%, p = .003). Among invasive cases, 32.3% had no detectable MRI abnormalities. The main indication for invasive evaluation was seizure onset localization (88.1%), followed by motor or sensory mapping (17.2%) and language mapping (14.2%). Stereoelectroencephalography (SEEG) was the predominant technique (19.8% overall, 93.6% of invasive cases), more common in North America (30.0%, p = .021) and less common in South America (7.4%, p < .001). Subdural electrodes were used in only 3.2% of invasive cases, and combined depth and subdural approaches in 3.2%. SEEG‐guided radiofrequency thermocoagulation (RF‐TC) was performed in 40.9% of SEEG cases, most commonly in Asia (63.8%). In 16.2% of invasive evaluations, patients did not proceed to resection, disconnection, or ablation, with the highest rate in Europe (28.5%). Significance: This global survey provides the first broad overview of invasive evaluation practices in pediatric epilepsy surgery across participating centers worldwide. It highlights the widespread adoption of SEEG, declining use of subdural electrodes, and increasing application of SEEG‐guided RF‐TC. The high proportion of MRI‐negative cases and the considerable proportion of patients not proceeding to resection, disconnection, or ablation underscore the complexity of contemporary surgical candidates and the need for further refinement of selection strategies.
Open AccessPediatric epilepsy surgery: Global survey of invasive explorations
Objective: Invasive presurgical evaluation plays a key role in pediatric epilepsy surgery, particularly in magnetic resonance imaging (MRI)‐negative cases, by guiding resective, disconnective, or ablative procedures. This International League Against Epilepsy (ILAE) Pediatric Epilepsy Surgery Taskforce study provides an updated global overview of current invasive evaluation practices. Methods: Group‐level data were collected from 61 epilepsy surgery programs (49 pediatric‐only) in 29 countries across six continents. Included were children and adolescents who underwent presurgical evaluation and epilepsy surgery in 2023. The study was designed to enable comparison with the similar ILAE survey conducted in 2004. Results: A total of 2427 patients were included. Invasive evaluations were performed in 21.1% of cases, most frequently in North America (33.7%, higher than Europe: 18.0%, p = .003). Among invasive cases, 32.3% had no detectable MRI abnormalities. The main indication for invasive evaluation was seizure onset localization (88.1%), followed by motor or sensory mapping (17.2%) and language mapping (14.2%). Stereoelectroencephalography (SEEG) was the predominant technique (19.8% overall, 93.6% of invasive cases), more common in North America (30.0%, p = .021) and less common in South America (7.4%, p < .001). Subdural electrodes were used in only 3.2% of invasive cases, and combined depth and subdural approaches in 3.2%. SEEG‐guided radiofrequency thermocoagulation (RF‐TC) was performed in 40.9% of SEEG cases, most commonly in Asia (63.8%). In 16.2% of invasive evaluations, patients did not proceed to resection, disconnection, or ablation, with the highest rate in Europe (28.5%). Significance: This global survey provides the first broad overview of invasive evaluation practices in pediatric epilepsy surgery across participating centers worldwide. It highlights the widespread adoption of SEEG, declining use of subdural electrodes, and increasing application of SEEG‐guided RF‐TC. The high proportion of MRI‐negative cases and the considerable proportion of patients not proceeding to resection, disconnection, or ablation underscore the complexity of contemporary surgical candidates and the need for further refinement of selection strategies.
- Open Access
Pediatric epilepsy surgery: Global survey of referral and presurgical evaluation practices
Objective: Pediatric epilepsy surgery is well established, but contemporary global data on referral and presurgical evaluation practices are lacking. This International League Against Epilepsy (ILAE) Pediatric Epilepsy Surgery Task Force study provides an updated overview of current trends and regional differences. Methods: Group‐level data were collected from 61 epilepsy surgery programs (49 pediatric‐only) across 29 countries and six continents, identified through ILAE networks, and included all children and adolescents treated in 2023 who underwent presurgical evaluation/epilepsy surgery. Results: Group‐level data were available for 2427 patients. Mean age at surgery was 9.1 ± 4.9 years; mean epilepsy duration was 5.3. At surgery, 3.2% were 5 years. Reoperations are common, with resection more frequent than neuromodulation. Genetic testing in nearly half of patients reflects its growing relevance, and the high rate of DEEs underscores the complexity of surgical candidates.
Open AccessPediatric epilepsy surgery: Global survey of referral and presurgical evaluation practices
Objective: Pediatric epilepsy surgery is well established, but contemporary global data on referral and presurgical evaluation practices are lacking. This International League Against Epilepsy (ILAE) Pediatric Epilepsy Surgery Task Force study provides an updated overview of current trends and regional differences. Methods: Group‐level data were collected from 61 epilepsy surgery programs (49 pediatric‐only) across 29 countries and six continents, identified through ILAE networks, and included all children and adolescents treated in 2023 who underwent presurgical evaluation/epilepsy surgery. Results: Group‐level data were available for 2427 patients. Mean age at surgery was 9.1 ± 4.9 years; mean epilepsy duration was 5.3. At surgery, 3.2% were 5 years. Reoperations are common, with resection more frequent than neuromodulation. Genetic testing in nearly half of patients reflects its growing relevance, and the high rate of DEEs underscores the complexity of surgical candidates.
Automated detection of bottom‐of‐sulcus dysplasia on magnetic resonance imaging–positron emission tomography in patients with drug‐resistant focal epilepsy
Objective: Bottom‐of‐sulcus dysplasia (BOSD) is a diagnostically challenging subtype of focal cortical dysplasia, 60% being missed on magnetic resonance imaging (MRI). Automated MRI‐based detection methods have been developed for focal cortical dysplasia, but not BOSD specifically, and few methods incorporate fluorodeoxyglucose positron emission tomography (FDG‐PET) alongside MRI features. We report the development and performance of an automated BOSD detector using combined MRI + PET. Methods: The training set comprised 54 patients with focal epilepsy and BOSD. The test sets comprised 17 subsequently diagnosed patients with BOSD from the same center, and 12 published patients from a different center. Across training and test sets, 81% of patients had normal initial MRIs and most BOSDs were 3 . In the training set, 12 features from T1‐MRI, fluid‐attenuated inversion recovery–MRI, and FDG‐PET were evaluated to determine which features best distinguished dysplastic from normal‐appearing cortex. Using the Multi‐centre Epilepsy Lesion Detection group's machine‐learning detection method with the addition of FDG‐PET, neural network classifiers were then trained and tested on MRI + PET, MRI‐only, and PET‐only features. The proportion of patients whose BOSD was overlapped by the top output cluster, and the top five output clusters, were determined. Results: Cortical and subcortical hypometabolism on FDG‐PET was superior in discriminating dysplastic from normal‐appearing cortex compared to MRI features. When the BOSD detector was trained on MRI + PET features, 87% BOSDs were overlapped by one of the top five clusters (69% top cluster) in the training set, 94% in the prospective test set (88% top cluster), and 75% in the published test set (58% top cluster). Cluster overlap was generally lower when the detector was trained and tested on PET‐only or MRI‐only features. Significance: Detection of BOSD is possible using established MRI‐based automated detection methods, supplemented with FDG‐PET features and trained on a BOSD‐specific cohort. In clinically appropriate patients with seemingly negative MRI, the detector could suggest MRI regions to scrutinize for possible BOSD.
Automated detection of bottom‐of‐sulcus dysplasia on magnetic resonance imaging–positron emission tomography in patients with drug‐resistant focal epilepsy
Objective: Bottom‐of‐sulcus dysplasia (BOSD) is a diagnostically challenging subtype of focal cortical dysplasia, 60% being missed on magnetic resonance imaging (MRI). Automated MRI‐based detection methods have been developed for focal cortical dysplasia, but not BOSD specifically, and few methods incorporate fluorodeoxyglucose positron emission tomography (FDG‐PET) alongside MRI features. We report the development and performance of an automated BOSD detector using combined MRI + PET. Methods: The training set comprised 54 patients with focal epilepsy and BOSD. The test sets comprised 17 subsequently diagnosed patients with BOSD from the same center, and 12 published patients from a different center. Across training and test sets, 81% of patients had normal initial MRIs and most BOSDs were 3 . In the training set, 12 features from T1‐MRI, fluid‐attenuated inversion recovery–MRI, and FDG‐PET were evaluated to determine which features best distinguished dysplastic from normal‐appearing cortex. Using the Multi‐centre Epilepsy Lesion Detection group's machine‐learning detection method with the addition of FDG‐PET, neural network classifiers were then trained and tested on MRI + PET, MRI‐only, and PET‐only features. The proportion of patients whose BOSD was overlapped by the top output cluster, and the top five output clusters, were determined. Results: Cortical and subcortical hypometabolism on FDG‐PET was superior in discriminating dysplastic from normal‐appearing cortex compared to MRI features. When the BOSD detector was trained on MRI + PET features, 87% BOSDs were overlapped by one of the top five clusters (69% top cluster) in the training set, 94% in the prospective test set (88% top cluster), and 75% in the published test set (58% top cluster). Cluster overlap was generally lower when the detector was trained and tested on PET‐only or MRI‐only features. Significance: Detection of BOSD is possible using established MRI‐based automated detection methods, supplemented with FDG‐PET features and trained on a BOSD‐specific cohort. In clinically appropriate patients with seemingly negative MRI, the detector could suggest MRI regions to scrutinize for possible BOSD.
- 18 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110589
Epilepsy surgery in infants and young children with tuberous sclerosis
- 18 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110589
Epilepsy surgery in infants and young children with tuberous sclerosis
- Open Access
Automated detection of bottom-of-sulcus dysplasia on MRI-PET in patients with drug-resistant focal epilepsy
Background and Objectives: Bottom-of-sulcus dysplasia (BOSD) is a diagnostically challenging subtype of focal cortical dysplasia, 60% being missed on patients’ first MRI. Automated MRI-based detection methods have been developed for focal cortical dysplasia, but not BOSD specifically. Use of FDG-PET alongside MRI is not established in automated methods. We report the development and performance of an automated BOSD detector using combined MRI+PET data. Methods: The training set comprised 54 mostly operated patients with BOSD. The test sets comprised 17 subsequently diagnosed patients with BOSD from the same center, and 12 published patients from a different center. 81% patients across training and test sets had reportedly normal first MRIs and most BOSDs were 3 . In the training set, 12 features from T1-MRI, FLAIR-MRI and FDG-PET were evaluated using a novel “pseudo-control” normalization approach to determine which features best distinguished dysplastic from normal-appearing cortex. Using the Multi-centre Epilepsy Lesion Detection group’s machine-learning detection method with the addition of FDG-PET, neural network classifiers were then trained and tested on MRI+PET features, MRI-only and PET-only. The proportion of patients whose BOSD was overlapped by the top output cluster, and the top five output clusters, were assessed. Results: Cortical and subcortical hypometabolism on FDG-PET were superior in discriminating dysplastic from normal-appearing cortex compared to MRI features. When the BOSD detector was trained on MRI+PET features, 87% BOSDs were overlapped by one of the top five clusters (69% top cluster) in the training set, 76% in the prospective test set (71% top cluster) and 75% in the published test set (42% top cluster). Cluster overlap was similar when the detector was trained and tested on PET-only features but lower when trained and tested on MRI-only features. Conclusion: Detection of BOSD is possible using established MRI-based automated detection methods, supplemented with FDG-PET features and trained on a BOSD-specific cohort. In clinical practice, an MRI+PET BOSD detector could improve assessment and outcomes in seemingly MRI-negative patients being considered for epilepsy surgery.
Open AccessAutomated detection of bottom-of-sulcus dysplasia on MRI-PET in patients with drug-resistant focal epilepsy
Background and Objectives: Bottom-of-sulcus dysplasia (BOSD) is a diagnostically challenging subtype of focal cortical dysplasia, 60% being missed on patients’ first MRI. Automated MRI-based detection methods have been developed for focal cortical dysplasia, but not BOSD specifically. Use of FDG-PET alongside MRI is not established in automated methods. We report the development and performance of an automated BOSD detector using combined MRI+PET data. Methods: The training set comprised 54 mostly operated patients with BOSD. The test sets comprised 17 subsequently diagnosed patients with BOSD from the same center, and 12 published patients from a different center. 81% patients across training and test sets had reportedly normal first MRIs and most BOSDs were 3 . In the training set, 12 features from T1-MRI, FLAIR-MRI and FDG-PET were evaluated using a novel “pseudo-control” normalization approach to determine which features best distinguished dysplastic from normal-appearing cortex. Using the Multi-centre Epilepsy Lesion Detection group’s machine-learning detection method with the addition of FDG-PET, neural network classifiers were then trained and tested on MRI+PET features, MRI-only and PET-only. The proportion of patients whose BOSD was overlapped by the top output cluster, and the top five output clusters, were assessed. Results: Cortical and subcortical hypometabolism on FDG-PET were superior in discriminating dysplastic from normal-appearing cortex compared to MRI features. When the BOSD detector was trained on MRI+PET features, 87% BOSDs were overlapped by one of the top five clusters (69% top cluster) in the training set, 76% in the prospective test set (71% top cluster) and 75% in the published test set (42% top cluster). Cluster overlap was similar when the detector was trained and tested on PET-only features but lower when trained and tested on MRI-only features. Conclusion: Detection of BOSD is possible using established MRI-based automated detection methods, supplemented with FDG-PET features and trained on a BOSD-specific cohort. In clinical practice, an MRI+PET BOSD detector could improve assessment and outcomes in seemingly MRI-negative patients being considered for epilepsy surgery.
- Open Access
Why did my seizures start now? Influences of lesion connectivity and genetic etiology on age at seizure onset in focal epilepsy
Objective: Patients with focal, lesional epilepsy present with seizures at variable ages. Larger lesion size and overlap with sensorimotor or default mode network (DMN) have been associated with younger age at seizure onset in cohorts with mixed types of focal cortical dysplasia (FCD). Here, we studied determinants of age at seizure onset in patients with bottom‐of‐sulcus dysplasia (BOSD), a discrete type of FCD with highly localized epileptogenicity. Methods: Eighty‐four patients (77% operated) with BOSD were studied. Demographic, histopathologic, and genetic findings were recorded. BOSD volume and anatomical, primary versus association, rostral versus caudal, and functional network locations were determined. Normative functional connectivity analyses were performed using each BOSD as a region of interest in resting‐state functional magnetic resonance imaging data of healthy children. Variables were correlated with age at seizure onset. Results: Median age at seizure onset was 5.4 (interquartile range = 2–7.9) years. Of 50 tested patients, 22 had somatic and nine had germline pathogenic mammalian target of rapamycin (mTOR) pathway variants. Younger age at seizure onset was associated with greater BOSD volume ( p = .002), presence of a germline pathogenic variant ( p = .04), DMN overlap ( p = .04), and increased functional connectivity with the DMN ( p < .05, false discovery rate corrected). Location within sensorimotor cortex and networks was not associated with younger age at seizure onset in our relatively small but homogenous cohort. Significance: Greater lesion size, pathogenic mTOR pathway germline variants, and DMN connectivity are associated with younger age at seizure onset in small FCD. Our findings strengthen the suggested role of DMN connectivity in the onset of FCD‐related focal epilepsy and reveal novel contributions of genetic etiology.
Open AccessWhy did my seizures start now? Influences of lesion connectivity and genetic etiology on age at seizure onset in focal epilepsy
Objective: Patients with focal, lesional epilepsy present with seizures at variable ages. Larger lesion size and overlap with sensorimotor or default mode network (DMN) have been associated with younger age at seizure onset in cohorts with mixed types of focal cortical dysplasia (FCD). Here, we studied determinants of age at seizure onset in patients with bottom‐of‐sulcus dysplasia (BOSD), a discrete type of FCD with highly localized epileptogenicity. Methods: Eighty‐four patients (77% operated) with BOSD were studied. Demographic, histopathologic, and genetic findings were recorded. BOSD volume and anatomical, primary versus association, rostral versus caudal, and functional network locations were determined. Normative functional connectivity analyses were performed using each BOSD as a region of interest in resting‐state functional magnetic resonance imaging data of healthy children. Variables were correlated with age at seizure onset. Results: Median age at seizure onset was 5.4 (interquartile range = 2–7.9) years. Of 50 tested patients, 22 had somatic and nine had germline pathogenic mammalian target of rapamycin (mTOR) pathway variants. Younger age at seizure onset was associated with greater BOSD volume ( p = .002), presence of a germline pathogenic variant ( p = .04), DMN overlap ( p = .04), and increased functional connectivity with the DMN ( p < .05, false discovery rate corrected). Location within sensorimotor cortex and networks was not associated with younger age at seizure onset in our relatively small but homogenous cohort. Significance: Greater lesion size, pathogenic mTOR pathway germline variants, and DMN connectivity are associated with younger age at seizure onset in small FCD. Our findings strengthen the suggested role of DMN connectivity in the onset of FCD‐related focal epilepsy and reveal novel contributions of genetic etiology.
- 6 November 2023
- Published by Oxford University Press (OUP) in Brain
- Vol. 147 (4) , 1264-1277
The clinical, imaging, pathological and genetic landscape of bottom-of-sulcus dysplasia
Bottom-of-sulcus dysplasia (BOSD) is increasingly recognised as a cause of drug-resistant, surgically-remediable, focal epilepsy, often in seemingly MRI-negative patients. We describe the clinical manifestations, morphological features, localisation patterns, and genetics of BOSD, with the aims of improving management and understanding pathogenesis. We studied 85 patients with BOSD diagnosed between 2005-2022. Presenting seizure and EEG characteristics, clinical course, genetic findings, and treatment response were obtained from medical records. 3T-MRI and 18F-FDG-PET scans were reviewed systematically for BOSD morphology and metabolism. Histopathological analysis and tissue genetic testing were performed in 64 operated patients. BOSD locations were transposed to common imaging space to study anatomical location, functional network localisation, and relationship to normal MTOR gene expression. All patients presented with stereotyped focal seizures with rapidly escalating frequency, prompting hospitalisation in 48%. Despite 42% patients having seizure remissions, usually with sodium channel blocking medications, most eventually became drug-resistant and underwent surgery (86% seizure-free). Prior developmental delay was uncommon but intellectual, language and executive dysfunction were present in 24%, 48% and 29% when assessed preoperatively, low intellect being associated with greater epilepsy duration. BOSDs were missed on initial MRI in 68%, being ultimately recognised following repeat MRI, 18F-FDG-PET or image post-processing. MRI features were grey-white junction blurring (100%), cortical thickening (91%), transmantle band (62%), increased cortical T1 signal (46%) and increased subcortical FLAIR signal (26%). BOSD hypometabolism was present on 18F-FDG-PET in 99%. Additional areas of cortical malformation or grey matter heterotopia were present in eight patients. BOSDs predominated in frontal and pericentral cortex and related functional networks, mostly sparing temporal and occipital cortex, and limbic and visual networks. Genetic testing yielded pathogenic mTOR pathway variants in 63% patients, including somatic MTOR variants in 47% operated patients and germline DEPDC5 or NPRL3 variants in 73% patients with familial focal epilepsy. BOSDs tended to occur in regions where the healthy brain normally shows lower MTOR expression, suggesting these regions may be more vulnerable to up-regulation of MTOR activity. Consistent with the existing literature, these results highlight (1) clinical features raising suspicion of BOSD, (2) the role of somatic and germline mTOR pathway variants in patients with sporadic and familial focal epilepsy associated with BOSD and (3) the role of 18F-FDG-PET alongside high-field MRI in detecting subtle BOSD. The anatomical and functional distribution of BOSDs likely explain their seizure, EEG, and cognitive manifestations, and may relate to relative MTOR expression.
- 6 November 2023
- Published by Oxford University Press (OUP) in Brain
- Vol. 147 (4) , 1264-1277
The clinical, imaging, pathological and genetic landscape of bottom-of-sulcus dysplasia
Bottom-of-sulcus dysplasia (BOSD) is increasingly recognised as a cause of drug-resistant, surgically-remediable, focal epilepsy, often in seemingly MRI-negative patients. We describe the clinical manifestations, morphological features, localisation patterns, and genetics of BOSD, with the aims of improving management and understanding pathogenesis. We studied 85 patients with BOSD diagnosed between 2005-2022. Presenting seizure and EEG characteristics, clinical course, genetic findings, and treatment response were obtained from medical records. 3T-MRI and 18F-FDG-PET scans were reviewed systematically for BOSD morphology and metabolism. Histopathological analysis and tissue genetic testing were performed in 64 operated patients. BOSD locations were transposed to common imaging space to study anatomical location, functional network localisation, and relationship to normal MTOR gene expression. All patients presented with stereotyped focal seizures with rapidly escalating frequency, prompting hospitalisation in 48%. Despite 42% patients having seizure remissions, usually with sodium channel blocking medications, most eventually became drug-resistant and underwent surgery (86% seizure-free). Prior developmental delay was uncommon but intellectual, language and executive dysfunction were present in 24%, 48% and 29% when assessed preoperatively, low intellect being associated with greater epilepsy duration. BOSDs were missed on initial MRI in 68%, being ultimately recognised following repeat MRI, 18F-FDG-PET or image post-processing. MRI features were grey-white junction blurring (100%), cortical thickening (91%), transmantle band (62%), increased cortical T1 signal (46%) and increased subcortical FLAIR signal (26%). BOSD hypometabolism was present on 18F-FDG-PET in 99%. Additional areas of cortical malformation or grey matter heterotopia were present in eight patients. BOSDs predominated in frontal and pericentral cortex and related functional networks, mostly sparing temporal and occipital cortex, and limbic and visual networks. Genetic testing yielded pathogenic mTOR pathway variants in 63% patients, including somatic MTOR variants in 47% operated patients and germline DEPDC5 or NPRL3 variants in 73% patients with familial focal epilepsy. BOSDs tended to occur in regions where the healthy brain normally shows lower MTOR expression, suggesting these regions may be more vulnerable to up-regulation of MTOR activity. Consistent with the existing literature, these results highlight (1) clinical features raising suspicion of BOSD, (2) the role of somatic and germline mTOR pathway variants in patients with sporadic and familial focal epilepsy associated with BOSD and (3) the role of 18F-FDG-PET alongside high-field MRI in detecting subtle BOSD. The anatomical and functional distribution of BOSDs likely explain their seizure, EEG, and cognitive manifestations, and may relate to relative MTOR expression.
- Open Access
Intrinsic and secondary epileptogenicity in focal cortical dysplasia type II
Objective: Favorable seizure outcome is reported following resection of bottom‐of‐sulcus dysplasia (BOSD). We assessed the distribution of epileptogenicity and dysplasia in and around BOSD to better understand this clinical outcome and the optimal surgical approach.Methods: We studied 27 children and adolescents with magnetic resonance imaging (MRI)‐positive BOSD who underwent epilepsy surgery; 85% became seizure‐free postresection (median = 5.0 years follow‐up). All patients had resection of the dysplastic sulcus, and 11 had additional resection of the gyral crown (GC) or adjacent gyri (AG). Markers of epileptogenicity were relative cortical hypometabolism on preoperative 18F‐fluorodeoxyglucose (FDG) positron emission tomography (PET), and spiking, ripples, fast ripples, spike–high‐frequency oscillation cross‐rate, and phase amplitude coupling (PAC) on preresection and postresection electrocorticography (ECoG), all analyzed at the bottom‐of‐sulcus (BOS), top‐of‐sulcus (TOS), GC, and AG. Markers of dysplasia were increased cortical thickness on preoperative MRI, and dysmorphic neuron density and variant allele frequency of somatic MTOR mutations in resected tissue, analyzed at similar locations.Results: Relative cortical metabolism was significantly reduced and ECoG markers were significantly increased at the BOS compared to other regions. Apart from spiking and PAC, which were greater at the TOS compared to the GC, there were no significant differences in PET and other ECoG markers between the TOS, GC, and AG, suggesting a cutoff of epileptogenicity at the TOS rather than a tapering gradient on the cortical surface. MRI and tissue markers of dysplasia were all maximal in the BOS, reduced in the TOS, and mostly absent in the GC. Spiking and PAC reduced significantly over the GC after resection of the dysplastic sulcus.Significance: These findings support the concept that dysplasia and intrinsic epileptogenicity are mostly limited to the dysplastic sulcus in BOSD and support resection or ablation confined to the MRI‐visible lesion as a first‐line surgical approach. 18F‐FDG PET and ECoG abnormalities in surrounding cortex seem to be secondary phenomena.
Open AccessIntrinsic and secondary epileptogenicity in focal cortical dysplasia type II
Objective: Favorable seizure outcome is reported following resection of bottom‐of‐sulcus dysplasia (BOSD). We assessed the distribution of epileptogenicity and dysplasia in and around BOSD to better understand this clinical outcome and the optimal surgical approach.Methods: We studied 27 children and adolescents with magnetic resonance imaging (MRI)‐positive BOSD who underwent epilepsy surgery; 85% became seizure‐free postresection (median = 5.0 years follow‐up). All patients had resection of the dysplastic sulcus, and 11 had additional resection of the gyral crown (GC) or adjacent gyri (AG). Markers of epileptogenicity were relative cortical hypometabolism on preoperative 18F‐fluorodeoxyglucose (FDG) positron emission tomography (PET), and spiking, ripples, fast ripples, spike–high‐frequency oscillation cross‐rate, and phase amplitude coupling (PAC) on preresection and postresection electrocorticography (ECoG), all analyzed at the bottom‐of‐sulcus (BOS), top‐of‐sulcus (TOS), GC, and AG. Markers of dysplasia were increased cortical thickness on preoperative MRI, and dysmorphic neuron density and variant allele frequency of somatic MTOR mutations in resected tissue, analyzed at similar locations.Results: Relative cortical metabolism was significantly reduced and ECoG markers were significantly increased at the BOS compared to other regions. Apart from spiking and PAC, which were greater at the TOS compared to the GC, there were no significant differences in PET and other ECoG markers between the TOS, GC, and AG, suggesting a cutoff of epileptogenicity at the TOS rather than a tapering gradient on the cortical surface. MRI and tissue markers of dysplasia were all maximal in the BOS, reduced in the TOS, and mostly absent in the GC. Spiking and PAC reduced significantly over the GC after resection of the dysplastic sulcus.Significance: These findings support the concept that dysplasia and intrinsic epileptogenicity are mostly limited to the dysplastic sulcus in BOSD and support resection or ablation confined to the MRI‐visible lesion as a first‐line surgical approach. 18F‐FDG PET and ECoG abnormalities in surrounding cortex seem to be secondary phenomena.
- Open Access
- 19 December 2022
- Published by Wiley in Epilepsia Open
- Vol. 8 (1) , 205-210
Basal ganglia dysplasia and mTORopathy: A potential cause of postoperative seizures in focal cortical dysplasia
Pathogenic somatic MTOR variants in the cerebral cortex are a frequent cause of focal cortical dysplasia (FCD). We describe a child with drug and surgery-resistant focal epilepsy due to FCD type II who developed progressive enlargement and T2 signal hyperintensity in the ipsilateral caudate and lentiform nuclei. Histopathology of caudate nucleus biopsies showed dysmorphic neurons, similar to those in resected cortex. Genetic analysis of frontal and temporal cortex and caudate nucleus identified a pathogenic somatic MTOR variant [NM_004958.4:c.4375G > C (p.Ala1459Pro)] that was not present in blood-derived gDNA. The mean variant allele frequency ranged from 0.4% to 3.2% in cerebral cortex and up to 5.4% in the caudate nucleus. The basal ganglia abnormalities suggest more widespread, potentially hemispheric dysplasia in this patient, consistent with the pathogenic variant occurring in early cerebral development. This finding provides a potential explanation for persistent seizures in some patients with seemingly complete resection of FCD or disconnection of a dysplastic hemisphere.
- 19 December 2022
- Published by Wiley in Epilepsia Open
- Vol. 8 (1) , 205-210
Open AccessBasal ganglia dysplasia and mTORopathy: A potential cause of postoperative seizures in focal cortical dysplasia
Pathogenic somatic MTOR variants in the cerebral cortex are a frequent cause of focal cortical dysplasia (FCD). We describe a child with drug and surgery-resistant focal epilepsy due to FCD type II who developed progressive enlargement and T2 signal hyperintensity in the ipsilateral caudate and lentiform nuclei. Histopathology of caudate nucleus biopsies showed dysmorphic neurons, similar to those in resected cortex. Genetic analysis of frontal and temporal cortex and caudate nucleus identified a pathogenic somatic MTOR variant [NM_004958.4:c.4375G > C (p.Ala1459Pro)] that was not present in blood-derived gDNA. The mean variant allele frequency ranged from 0.4% to 3.2% in cerebral cortex and up to 5.4% in the caudate nucleus. The basal ganglia abnormalities suggest more widespread, potentially hemispheric dysplasia in this patient, consistent with the pathogenic variant occurring in early cerebral development. This finding provides a potential explanation for persistent seizures in some patients with seemingly complete resection of FCD or disconnection of a dysplastic hemisphere.